Abstract
Clinical trials demonstrate that intensive treatment of early rheumatoid arthritis with a combination of DMARDs improves short-term outcomes. an extension study from a pivotal trial has now shown that such intensive early therapy can achieve a reduction in the rate of erosive progression over a period of 11 years.
Original language | English |
---|---|
Pages (from-to) | 623 - 624 |
Number of pages | 2 |
Journal | Nature Reviews Rheumatology |
Volume | 6 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2010 |